With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence in Denmark to a three-month low. Denmark’s confidence index fell to -17.2 this month, according to official ...

Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 percent ...

I’ve seen what happens to people who use counterfeit skinny jabs – as unwittingly happened to the reality star Aisleyne ...

With the cost of the weight-loss jab set to rise by up to 170 per cent, Jade Kay, who has already spent £2,400 on the drug, says she will take a second job waitressing if she has to ...

Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.